Stay updated on Magrolimab Combo in AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab Combo in AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    2%
    Check dated 2025-10-06T05:31:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Additions introduce revision v3.1.0; deletions remove several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and include an older version tag v3.0.2. The page’s scope appears to contract around safety topics while updating its version.
    Difference
    0.2%
    Check dated 2025-09-29T03:03:49.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:21:17.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T16:43:06.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as recent publications related to acute myeloid leukemia and associated treatments. Notably, the drug names venetoclax and azacitidine have been emphasized in the context of drug safety.
    Difference
    14%
    Check dated 2025-08-31T12:02:36.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.4%
    Check dated 2025-08-24T08:00:00.000Z thumbnail image

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.